Mergen.financeAbbott Laboratories
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sept | Oct | Nov | Dec | Year |
|---|
| 2026 | ▼ 12.8% | ▲ 6.5% | ▼ 11.8% | ▼ 11.6% | ▼ 5.7% | ▲ 6.0% | ▲ 16.5% | ▲ 4.4% | ▼ 10.4% | ▲ 7.5% | ▲ 8.8% | ▼ 7.8% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | ▼ 2.8% |
From our own closes, each month-end against the previous month-end. Colour saturates at ▲ 12.8%; an empty cell means no data, a dash means we declined to derive one.
Fiscal period: FY · 2025-12-31 (10-K) — annual data, not TTM · USD · Source: SEC EDGAR (public domain)
Balance-sheet lines and ratios (assets, equity, ROE, ROA, net margin, debt/equity) open on the paid plans. See the plans
Locked content: requires the Mergen plan
1 of 180 rows open
Data: Twelve Data · before August 2026, the Marketstack archive